Lɛ wi lan bɔt Jiografik Atrofi, we kin afɛkt yu vishɔn kwayɛt wan.

Sɔntɛnde yu kin fil lɛk se yu de si smɔl smɔl, mɔ we yu luk stret bifo yu, ɛn di say we yu de si nɔ klia, lɛk dak ples? Yu kin si am se i nɔ kin izi fɔ yu fɔ rid buk ɔ nyuspepa, ɔ fɔ si tin dɛn na dak? So, tide wi go tɔk bɔt Jiografik Atrofi, we na wan ay kɔndishɔn we kin apin to sɔm pipul dɛn we dɔn ol. Nɔ wɔri, i rili impɔtant fɔ no bɔt dis.

Wetin na Jiografik Atrofi?

Fɔ tɔk am simpul wan, Jiografik Atrofi na di mɛrɛsin nem fɔ di mɔs siriɔs, las stej fɔ dray ej-rilayt makula dijɛnɛreshɔn (AMD), we na wan sik we kin afɛkt di yay as wi de ol. Yu go dɔn yɛri bɔt macular degeneration. Dis na we di makula , we na wan rili impɔtant pat pan di retina we de insay wi yay, kin pwɛl.

Tink bɔt am, di tin dɛn we yu kin si klia wan we yu luk stret bifo, lɛk di lɛta dɛn we yu de rid buk, ɔ di fes we yu luk pɔsin, na ɔl di tin dɛn we di makula de ɛp wi fɔ si klia wan. So, we Jiografik Atrofi de apin, na di sɛntral vishɔn we dɛn kin afɛkt mɔ. Bɔt, yu kin stil si di say we yu de si di say we yu de si, ɔ tin dɛn we yu kin si frɔm di sayd dɛn.

dis kכndyushכn kin afekt כl tu di yay dεm (baylaterally). Pɔsin we gɛt jiografik atrofi kin gɛt dak ples (skɔtoma) na di sɛntrɔm pan in yay we i de luk stret bifo, ɛn di we aw i kin si kin stɔp.

Aw kɔmɔn tin na Jiografik Atrofi?

I de afɛkt pas 8 milyɔn pipul dɛn ɔlsay na di wɔl. Jiografik Atrofi na wan kכndyushכn we de afekt bכt 20% pan di pipul dεm we gεt εj-rεlatεd makyula dεjεnεreshכn (AMD). So, i nɔto so tin we nɔ kɔmɔn.

Wetin na di sayn dɛm fɔ Jiografik Atrofi?

We dis kayn tin kin apin, yu kin gɛt sɔm kayn sik lɛk:

• Lɔs fɔ si : Fɔ tɔk di kɔrɛkt tin , tin nɔ kin klia ɛn shap.
• I nɔ izi fɔ rid, drayv, ɛn du wok wit yu an : I kin at fɔ du ɛni wok we nid fɔ si stret. Tin dɛn lɛk fɔ rid smɔl smɔl tin dɛn na nyuspepa, fɔ wach tɛlivishɔn, ɔ fɔ trɛd nidul kin at.
• Wan dak ples, ɔ blaynd ples, na yu sɛntral vishɔn: Na di say nɔmɔ we yu de luk de sho blak, lɛk blank ples.
• I nɔ izi fɔ si na say we layt nɔ de : Na ivintɛm, tin nɔ kin izi fɔ si na say dɛn we layt nɔ de.
• Kɔlɔ dɛn we de tɔn dɔl ɔ we nɔ de shayn bɛtɛ : Tin dɛn we bin de luk fayn trade trade kin tan lɛk se dɛn dɔn dɔl smɔl ɛn dɛn nɔ gɛt kɔlɔ.

di imכtant tin na dat, Jiografik Atrofi na wan kכndyushכn we de apin na di εnd fכ di εj-rεlatεd makyula dεjεnεreshכn. So, yu nɔ go notis ɛni sayn we yu bigin , ɔ yu nɔ go notis bɔku difrɛns if na wan yay nɔmɔ i afɛkt.

Wetin na di tin dɛn we kin mek pɔsin gɛt Jiografik Atrofi?

As wi bin dɔn tɔk, dis na di las stej fɔ dray AMD. Risach pipul dεm stil nכ no εksεkεkt wetin kin mek dεn chenj dεm ya insay di yay de divεlכp to jכgrafik atrofi. Bɔt dɛn tink se wan tin we dɛn kɔl kɔmplimɛnt kaskad , we na pat pan wi bɔdi in imyun sistɛm, de insay. Dis min se sɔm prɔses na wi bɔdi in difɛns sistɛm kin nɔ de wok fayn ɛn i kin mek dis damej. pan tap dat, di jεnεtik fכktכ dεm (i.e., tin dεm we de pas dכn frכm jεnereshכn to jεnereshכn) εn di envayroment fכktכ dεm kin ple rol bak.

Di tin we impɔtant pas ɔl fɔ mɛmba na dat di atrofi we de na di say we pɔsin de nɔto sik we pɔsin kin gɛt . Yu nɔ go ebul fɔ spre am to ɔda pɔsin.

Udat de pan big risk fɔ gɛt di atrofi we de na di say we i de?

Pan ɔl we dis sik kin kam pan ɛnibɔdi, sɔm pipul dɛn kin gɛt bɔku prɔblɛm. Dɛn tin ya na:

• Pipul dɛn we ol 60 ia ɔ pas dat.
• Wait pipul (pan ɔl we dis nɔ rili impɔtant to Sri Lanka, i fayn fɔ no).
• Pipul dɛn we gɛt layt kɔlɔ yay.
• If sɔmbɔdi na yu famili gɛt makula dijenereshɔn we gɛt fɔ du wit di ej ɔ ɔda kayn jenɛtik sik we kin afɛkt di yay.
• Pipul dɛn we de smok ɔ we dɔn smok trade.
• Pipul dɛn we de it it we nɔ gɛt bɔku frut ɛn vɛjitebul, mɔ di dak grɛn lif vɛjitebul dɛn, rili impɔtant fɔ di ay wɛlbɔdi.
• Pipul dɛn we de na di san pasmak.
• Pipul dεm wae gεt vishכn 20/200 כ wכs (dεn kin kכnsidr nכmal vishכn 20/20).

Apat frɔm dat, pipul dɛm wae gɛt ɔda sik dɛm lɛk:

• Malnutrishɔn
• Fat
• Di ay blɔd prɛshɔn
• Kɔlestɔl we bɔku
• Dayabitis `(Dayabetis Mɛlitus)`
• Koronari at sik

Wetin na di kɔmplikeshɔn dɛm wae de kam wit Jiografik Atrofi?

Bɔt i sɔri fɔ no se di we aw pɔsin kin si tin bikɔs i nɔ de si fayn, i kin de sote go . Wae yu nɔr de si yu stret, i kin tranga fɔ du ɛvride wok lɛk:

• Fɔ rid buk dɛn.
• Fɔ drayv.
• Fɔ no pipul dɛn fes.
• Fɔ du di tin dɛn we yu kin lɛk fɔ du, di wok dɛn we yu kin du na os, ɔ di wok dɛn we yu kin du wit yu an.

Dis kin mek layf tranga smɔl, bɔt we dɛn de fɔ ɛp yu fɔ bia wit di prɔblɛm.

Aw dɛn kin no se pɔsin gɛt Jiografik Atrofi?

Yu ay spɛshal dɔktɔ go no dis sik tru wan ay ɛgzam ɛn ɔda tɛst dɛm. Di dɔktɔ go aks yu bak bɔt yu sik, ɛni ɔda mɛrɛsin we yu gɛt, ɛn if ɛnibɔdi na yu famili dɔn gɛt dis kayn sik.

Us tɛst dɛn kin du fɔ dis?

Fɔ no if yu gɛt atrofi na di say we yu de, yu yay dɔktɔ kin ɔda fɔ du tɛst lɛk:

• Fundus autofluorescence : Dis na we fכ tek pikchכ fכ di rεtina insay di yay. Insay dis, sɔm tin dɛn we de na di retina lɛk lipofuscin , de shayn ɔnda spɛshal layt we nɔ nid fɔ gɛt ɛni ay drɔp. Dis kin ɛp fɔ no usay dɛn dɔn pwɛl.
• Optical coherence tomography (OCT): dis na wan we bak we nכ de invayd fכ tek pikchכ fכ di rεtina. I de yuz layt we de riflekt. i de tek wan kכros-sekshכn pan di rεtina εn i kin si aw di damej de.
• Microperimetry : Dis na we fɔ tɛst yu vishɔnal fil. Dis min se yu kin si aw fa yu kin si ɛn if ɛni dak say de na yu yay.
• Multifocal electroretinography : insay dis tεst, dεn de shayn layt pan yu rεtina εn dεn de mכsu di ilektrikal aktiviti we de ansa.

If dɛn tɛst ya tan lɛk se dɛn kɔmplikt smɔl, nɔ wɔri. Yu dɔktɔ go ɛksplen ɔltin to yu.

Wetin na di tritmɛnt dɛm fɔ Jiografik Atrofi?

Di gud nyus na dat, i nɔ tu te yet we di U.S. Food and Drug Administration (FDA) dɔn gri fɔ yuz tu mɛrɛsin fɔ di fɔs tɛm fɔ trit di say we dɛn de kɔl di say we dɛn de. Dɛn na pegcetacoplan (SYOFOVRETM) ɛn avacincaptad pegol (IZERVAYTM). Dis na injɛkshɔn dɛn we dɛn kin put insay yu yay . Dɛn injɛkshɔn ya kin slo di prɔgrɛs fɔ di jiografik atrofi. Yu yay dɔktɔ go injekt dɛn mɛrɛsin ya na yu yay wan tɛm insay di mɔnt ɔ ɛvri tu mɔnt.

Apat frɔm dat, yu yay dɔktɔ kin tɛl yu ɔda we dɛn fɔ kɔntrol di say we yu de, lɛk:

• Visual rehabilitation : Yu kin nid tin dɛn fɔ si, lɛk spɛshal glas ɔ magnifying glas, fɔ ɛp yu fɔ du yu wok dɛn we yu de du ɛvride.
• AREDS2 SuplimɛntAREDS2 supliment: Dɛn bin tɛst dɛn antiɔksidant supamakit ya na di Age-Related Eye Disease Study. Sɔm dɔktɔ dɛn kin yuz dɛn fɔ trit dray AMD. Di ɔrijinal AREDS1 fɔmula bin inklud beta-karotin wit dɛn tin ya. Bɔt bikɔs beta-karotin gɛt fɔ du wit di risk fɔ gɛt lɔng kansa pan pipul dɛn we de smok, AREDS2 inklud bak lutein , zeaxanthin, vitamin E, zinc oxide , ɛn cupric oxide.
• Implantable miniature telescope (IMT): Dis min se yu fɔ ɔpreshɔn yu yay in natura lens ɛn put dis smɔl tɛliskɔp insay. dis divays de mek tin dεm we dεn de si dairekt wan big εn i de fכkus dεm pan כda εria dεm na di rεtina we stil de wok fayn fayn wan.

Ɛni bad tin de we di tritmɛnt kin du?

Bikɔs di nyu vaysin dɛn we dɛn kɔl Pegcetacoplan ɛn Avacincaptad pegol stil rili nyu, masta sabi pipul dɛn stil de stɔdi aw dɛn go wok ɛn di prɔblɛm dɛn we dɛn kin gɛt. Naw, dɛn no se dɛn sayd ɛfɛkt ya kin apin:

• Ay pen.
• Wan blɔd we de kɔmɔt na di wayt pat na di yay (Subconjunctival hemorrhage).
• di apinεns fכ flot dεm na di fluid insay di yay (vitreous humor).
• Niovaskulayzeshɔn na di yay.

I impɔtant fɔ tɔk to yu dɔktɔ bɔt dis ɛn pik di tritmɛnt we go fayn fɔ yu.

Yu tink se dɛn kin mek dɛn nɔ gɛt Jiografik Atrofi?

Fɔ tɔk tru, no we nɔ de fɔ mek dɛn nɔ gɛt di atrofi we de na di say we dɛn de, bikɔs dɛn nɔ go ebul fɔ stɔp di makula dijenereshɔn we kin kam wit di ej we kin mek i nɔ gɛt am.

Bɔt yu kin tray fɔ ridyus di prɔblɛm we yu gɛt fɔ gɛt dis. Dat min se wi fɔ pe atɛnshɔn to di modifyable risk factors we wi kin chenj. Wi nɔ go ebul fɔ chenj tin dɛn lɛk ej ɛn rays. Bɔt yu kin ɛp fɔ ridyus di prɔblɛm we yu gɛt bay we yu du dɛn tin ya:

• Nɔto fɔ smok. If yu de smok, tray fɔ lɛf fɔ smok.
• Gud kɔntrol fɔ sik dɛn we nɔ de mɛn lɛk dayabitis, ay blɔd prɛshɔn, fat, ɛn ay kɔlɔstrel.
• Wear sanglas wit yɔlɔ lens fɔ protɛkt yu yay we yu de go na do na di san.
• Wear di rayt sef glas we yu de wok, we yu de ple spɔt, ɔ we yu de du tin dɛn we yu lɛk fɔ du.
• Yu fɔ fala wan fayn it ɛn ɛksesaiz plan. Ɛspɛshali, put grɛn vɛjitebul, ɛvbɔdi, ɛn frut dɛn na yu it.

Wetin kin apin if a gɛt Jiografik Atrofi?

In jɛnɛral, di lukin-grɔn fɔ pipul dɛm wae gɛt jiografik atrofi nɔr kin rili fayn pan di vishɔn. Bɔt di sik kin afɛkt ɛnibɔdi difrɛn we. Nyu tritmɛnt dɛn dɔn briŋ sɔm ​​op.

Di tin we impɔtant pas ɔl na dat, Jiografik Atrofi nɔto sik we de kil pɔsin ɛn i nɔ go afɛkt yu layf.

Ustɛm a fɔ go to dɔktɔ?

Yu yay dɔktɔ go tɛl yu aw ɔltɛm yu fɔ chɛk yu yay. Tɛl yu dɔktɔ wantɛm wantɛm if yu notis ɛni chenj na yu yay ɔ yu yay.

If yu nɔ de si fayn wantɛm wantɛm ɔ yu yay de fil bad bad wan, i impɔtant fɔ go to dɔktɔ wantɛm wantɛm.

Us kwɛstyɔn dɛn a fɔ aks di dɔktɔ?

We yu go si dɔktɔ, yu kin aks kwɛstyɔn dɛn lɛk:

• A gɛt jiografik atrofi ɔ ɔda sik na mi yay?
• Us tɛst dɛn a nid fɔ du?
• A fit fɔ gɛt nyu mɛrɛsin fɔ trit jiografik atrofi?
• Aw ɔltɛm a fɔ mek dɛn chɛk mi yay?
• A kin tek pat pan klinik trial?
• Us chenj dɛn na mi yay a fɔ wach fɔ?
• Yu kin ɛp mi fɔ fɛn sɔpɔt savis dɛn we go ɛp mi?

Fɔ dɔn, tin dɛn we wi fɔ mɛmba

I fayn fɔ no se nyu tritmɛnt dɛn de fɔ di jiografik atrofi ɛn di risach de kɔntinyu. Bɔt, na nɔmal tin fɔ mek yu fred we yu kam fɔ no se yu gɛt wan sik we go afɛkt yu yay fɔ ɔltɛm.

Nɔ wɔri. Yu yay dɔktɔ go tɛl yu mɔ bɔt dis sik, wetin yu kin ɛkspɛkt, ɛn di bɛst tritmɛnt fɔ ɛp yu fɔ kɔntrol am. I impɔtant fɔ fala yu dɔktɔ in instrɔkshɔn ɛn du ɛgzam fɔ yu yay ɔltɛm . Dɔn bak, di sɔpɔt we yu famili go sɔpɔt yu go rili ɛp yu insay dis tɛm.

Jiografik Atrofi, Makula Dijɛnɛreshɔn we gɛt fɔ du wit di ej, AMD, Makula, Ay Hɛlth, Vishɔn Lɔs, Ay Sik